Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)

Lasers in Surgery and Medicine

Volumn 40, Issue 8, 2008, Pages 529-534

  Spaliviero, Massimiliano ^a   Araki, Motoo ^a   Page, Jay B ^a   Wong, Carson ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Catheter duration; KTP laser; LBO laser; Lower urinary tract symptoms; Outcomes

Indexed keywords

LITHIUM; LITHIUM TRIBORATE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LASER PHOTOSELECTIVE VAPORIZATION PROSTATECTOMY; LOW LEVEL LASER THERAPY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REPEAT PROCEDURE; SAFETY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; URETHRAL CATHETER; URETHRAL CATHETERIZATION; UROFLOWMETRY; VAPORIZATION;

AGED; AGED, 80 AND OVER; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATISM; URETHRA; URINARY CATHETERIZATION;

EID: 53249144149     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20678     Document Type: Article

References (19)

1. Committee APG: AUA Guidelines on Management of Benign Prostatic Hyperplasia. Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-547.
2. Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006;176:1500-1506.
3. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Muller A, Sulser T. Photoselective vaporization of the prostate: The basel experience after 108 procedures. Eur Urol 2005;47:798-804.
4. Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, Lehmann K, Sulser T. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): A prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-972.
5. Malek RS, R.S K, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005;174:1344-1348.
6. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first united states multicenter prospective trial. J Urol 2004;172:1404-1408.
7. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: Early results of a randomized trial. J Endourol 2006;20:580-585.
8. Wong C, Araki M, Tonkin JB. High-power potassyum-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: A systematic approach. J Endourol 2007;21:1141-1144.
9. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51:1031-1041.
10. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: Long-term results in 240 patients. J Endourol 2005;19:1199-1202.
11. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl- phosphate laser vaporization of the prostate: A comparative functional and pathologic study in canines. Urology 1996;48:575-583.
12. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-1159.
13. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of > 100 mL. BJU Int 2007;100:593-598.
14. Woo H, Reich O, Bachmann A, Choi B, Collins E, de la Rosette J, Gomez Sancha F, Muir GH, Tabatabaei S. Outcome of greenlight HPS 120-W laser therapy in specific patient populations: Those in retention, on anticoagulants, and with large prostates (≥80 ml). Eur Urol 2008;Suppl 7:378-383.
15. Muir GH, Gomez Sancha F, Bachmann A, Choi B, Collins E, de la Rosette J, Reich O, Tabatabaei S, Woo H. Techniques and training with greenlight HPS 120-W laser therapy of the prostate: Position paper. Eur Urol 2008;Suppl 7:370-377.
16. Ahmed HU, Thwaini A, Shergill IS, Hammadeh MY, Arya M, Kaisary AV. Greenlight prostatectomy: A challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech 2007;17:156-163.
17. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49:961-969.
18. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80W) potassium-tytanil-phospsphate laser vaporization of the prostate in 66 high risk patients. 2005; J Urol 173:158.
19. Tugcu V, Tasci AI, Ordekci Y, Ozbek E, Sahin S, Kantay K, Ozbay B. Short term outcomes of high power (80W) potasium-tytanil-phosphate laser vaporization of the prostate. Eur Urol 2005;48:608-613.